Astellas MEA was established in November 2014. Based in Dubai, United Arab Emirates, it represents a subsidiary of Astellas Pharma Inc. The regional affiliate serves as a management hub to further expand and develop Astellas’ business activities across the territory.
Our aim is to make a positive difference to the patients in the MEA region by providing innovative pharmaceutical products to patients with unmet medical needs.
Astellas MEA covers the Middle East, North Africa and Sub-Saharan Africa region. With the network of more than 40 business partners and approximately 190 employees, we serve over 40 countries. Our success is driven by highly talented teams who join Astellas with a proven track record and experience in the pharmaceutical industry both regionally and globally. This regional expertise enables us to understand the needs existing within our culturally diverse environment and to reflect this in everything we do. In addition, it ensures that we have the crucial local knowledge required to improve and extend access to our portfolio of innovative medicines to our patients across the region.
At the heart of everything we do, we aim to help and support more patients in the MEA Region. We are driven by our company-wide ethos of CHANGING TOMORROW™.
In MEA, we focus on the therapy areas of Transplantation, Oncology and Urology. In addition, Astellas MEA is committed to developing a portfolio of treatments to fulfill unmet medical needs in the Anti-Infectives therapy area within the region.
Our emphasis in the next three years will be on expanding and developing individual country organizations, which includes establishing ourselves in markets where we do not yet have a presence.